Belite Bio, Inc. ADR Financial Overview
Belite Bio, Inc. ADR's market cap is currently $5.39B. The company's EPS TTM is $-0.65; its P/E ratio is -80.48; Belite Bio, Inc. ADR is scheduled to report earnings on November 10, 2025, and the estimated EPS forecast is $-0.53. See an overview of income statement, balance sheet, and cash flow financials.
